Why iSpecimen Shares Are Gaining Today?

Why iSpecimen Shares Are Gaining Today?
  • iSpecimen Inc ISPC has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research.
  • The new suppliers include a cancer-focused biobank in the U.S., which contains a differentiated range of pre-and post-treatment tissue and biofluids across multiple cancer types. 
  • These samples provide rich genetic, treatment, follow-up, and outcome information. 
  • Additionally, iSpecimen has retained a European biobank with a vast urine and blood sample inventory from healthy participants aged 45 to 75, collected with participant health data generated from questionnaires and disease diagnoses. 
  • This biobank contains vital early-onset cancer and cardiovascular disease samples, as well.
  • iSpecimen offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers with access to patients and specimens needed for medical discovery.
  • Price Action: ISPC shares are up 21.50% at $2.88 during the market session on the last check Thursday.

Posted In: Briefswhy it's movingNewsPenny StocksHealth CareMoversTrading IdeasGeneral